Date(s) - 28 Apr 2020
9:00 AM - 9:45 AM
Multi-modal ATMP facilities to satisfy growing demand
This webinar will focus on how to deliver multi-product Advanced Therapy Medicinal Product (ATMP) facilities to adapt to an evolving product pipeline.
Between newly developed products, strategic partnerships, and acquisitions in the ATMP market, companies are racing to find or create capacity for viral vectors, gene modified cell therapies, and monoclonal antibodies.
A dedicated manufacturing facility can be costly, and limits options for the future. Why not have a facility that can produce multiple product types to allow for adaptability to an evolving product pipeline?